Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 4 results for "Medtronic Infuse Lawsuit News"

Medtronic Pays $2.8 Million to Settle Another Off-Label Case

The settlement, involving marketing of a pain procedure, is a tiny fraction of Medtronic's annual sales. Chris Newmarker Medtronic recently agreed to pay the U.S. government $2.8 million to resolve accusations that it encouraged off-label use ... QMED, 2 weeks ago

ACORDA THERAPEUTICS INC - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in this Annual Report on Form 10-K. ...
 Pharmacy Choice16 hours ago

Anchor Capital: Essential market review, 18 February

By Anchor Capital Click here to view this Anchor Capital review as a PDF South African Market Review South African markets closed lower yesterday, with the benchmark index snapping its three day winning streak. Gold miners, Harmony ...
 BizNews.com1 week ago

U.S. Orthopedic Biomaterials Market

The U.S. orthopedic biomaterials market will undergo increasing growth through 2021, resulting in a market value of nearly $3.9 billion by that year. The U.S. orthopedic biomaterials market includes bone graft substitutes, growth factors, ...
 Global Information Inc1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less